Combination therapy with anticoagulants, corticosteroids and intravenous immunoglobulin for women with severe obstetric antiphospholipid syndrome.

Watanabe, N; Yamaguchi, K; Motomura, K; Hisano, M; Sago, H; Murashima, A

Watanabe, N; Yamaguchi, K; Motomura, K; Hisano, M; Sago, H; Murashima, A.

Affiliation

Watanabe N; Department of Maternal-Fetal and Neonatal Medicine, National Center for Child Health and Development, 2-10-1, Okura Setagaya, Tokyo, Japan. watanabe-n@ncchd.go.jp.

Clin Exp Rheumatol ; 32(2): 299-300, 2014.

Article in En | MEDLINE | ID: mdl-24447427

Subject(s)

Anticoagulants/administration & dosage; Antiphospholipid Syndrome; Glucocorticoids/administration & dosage; Immunoglobulins, Intravenous/administration & dosage; Adult; Antiphospholipid Syndrome/diagnosis; Antiphospholipid Syndrome/drug therapy; Antiphospholipid Syndrome/physiopathology; Drug Therapy, Combination/methods; Female; Humans; Immunologic Factors/administration & dosage; Monitoring, Immunologic; Pregnancy; Pregnancy Complications/diagnosis; Pregnancy Complications/drug therapy; Pregnancy Complications/physiopathology; Severity of Illness Index; Treatment Outcome

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: Immunoglobulins, Intravenous / Antiphospholipid Syndrome / Glucocorticoids / Anticoagulants Type of study: Diagnostic_studies Limits: Adult / Female / Humans / Pregnancy Language: En Journal: Clin Exp Rheumatol Year: 2014 Type: Article Affiliation country: Japan

Search on Google

Add to My VHL

XML

PubMed Links